Contact Person

Dr. Elinor Switzer

Managing Editor

Phone: +49 (0)711 - 8931-230
Fax: +49 (0)711 - 8931-323
send an Email


Fibrinogen gamma gene 3’-end polymorphisms and risk of venous thromboembolism in the African-American and Caucasian population

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245

Recent advances in vascular biology: Selected highlights from IVBM 2008

Issue: 2009: 101/6 (June) pp. 796-1180
Pages: 1078-1084

Fibrinogen gamma gene 3’-end polymorphisms and risk of venous thromboembolism in the African-American and Caucasian population

Shirley Uitte de Willige 1; Meridith E. Pyle 2; Hans L. Vos 1; Marieke C. H. de Visser 1; Cathy Lally 3; Nicole F. Dowling 2; W. Craig Hooper 2; Rogier M. Bertina 1; Harland Austin3
1 Einthoven Laboratory for Experimental Vascular Medicine, Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands; 2 Division of Hereditary Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; 3 Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA


risk, venous thromboembolism, polymorphisms, African-Americans, fibrinogen gamma


Genetic determinants of venous thromboembolism (VTE) in the African-American population are poorly characterised. It was recently shown that fibrinogen gamma gene (FGG) polymorphisms 10034C>T and 9340T>C influence VTE risk in the Caucasian population. In the African-American population these polymorphisms are common, with allele frequencies above 25%. Here we evaluated whether these and other FGG 3’-end polymorphisms were associated with VTE risk in the African-American population and aimed to replicate the association in the Caucasian population. We examined 557 Caucasian patients and 678 Caucasian controls, and 537 African-American patients and 586 African-American controls from the ‘Genetic Attributes and Thrombosis Epidemiology’ (GATE) study. In the African-American population, 10034C>T and 9340T>C marginally influenced VTE-risk, with a 20% increase in risk for 10034TT carriers and a 20% reduction in risk for 9340CC carriers. In the Caucasian population, 10034TT was associated with a 1.7-fold increase in risk, which increased to 2.1-fold for idiopathic VTE patients. 9340CC significantly reduced VTE risk approximately two-fold. In conclusion, both FGG polymorphisms 10034C>T and 9340T>C influence VTE-risk, with the strongest effects observed in the Caucasian population, confirming previous data on these polymorphisms in this population.

You may also be interested in...

A systematic review

G. Lippi (1), C. Mattiuzzi (2), M. Franchini (3)

Thromb Haemost 2015 114 5: 958-963

Nienke Folkeringa 1, Michiel Coppens 2, Nic J. G. M. Veeger 1, Victor J. J. Bom 3, Saskia Middeldorp 2, Karly Hamulyak 4, Martin H. Prins 5, Harry R. Büller 2, Jan van der Meer1

Thromb Haemost 2008 100 1: 38-44

S. Schulman

Hämostaseologie 2008 28 3: 110-119